1
|
Sun N, Ma S, Jin L, Wang Y, Zhou C, Zhang X, Kang H, Yuan Y, Zhang Y, Yang H, Zhou M, Shu P. Unveiling the Anticancer Mechanism of Echinops davuricus: Isolation and Evaluation of AKR1B10 Inhibitors. Chem Biodivers 2024; 21:e202302053. [PMID: 38270380 DOI: 10.1002/cbdv.202302053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 01/24/2024] [Accepted: 01/25/2024] [Indexed: 01/26/2024]
Abstract
Five compounds (1-5), one long-chain fatty acid (1), two thiophenes (2 and 3), one alkaloid (4), and one phenyl ester (5), were isolated from the aerial part of Echinops davuricus. The structures of the products were established by performing detailed nuclear magnetic resonance (NMR) analysis, and the structure of compound 1 was determined via high-resolution electrospray ionization mass spectrometry (HRESIMS) and NMR. Compounds 1, 4, and 5 were isolated from Echinops davuricus for the first time. Based on network pharmacology methods, AKR1B10 was selected as a key anticancer target. Compounds 1 and 5 exhibited significant AKR1B10 inhibitory activities, with IC50 values of 156.0±1.00 and 146.2±1.50 nM, respectively, with epalrestat used as the positive control (81.09±0.61 nM). Additionally, the interactions between the active compounds and AKR1B10 were evaluated via molecular docking. Ultimately, the GO and KEGG enrichment analysis indicated that the key signaling pathways associated with the active compounds may be related to the PI3K-Akt, MAPK, apoptotic, cellular senescence, and TNF signaling pathways and the human diseases corresponding to the targets are cancer. Our study reveals for the first time the anticancer properties of Echinops davuricus and provides a comprehensive understanding of its application in traditional medicine.
Collapse
Affiliation(s)
- Na Sun
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Shuo Ma
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Linxuan Jin
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Yujing Wang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Caihong Zhou
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Xin Zhang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Huanhuan Kang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Yuhan Yuan
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Yu Zhang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Huanhuan Yang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Miao Zhou
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| | - Penghua Shu
- Food and Pharmacy College, Xuchang University, Xuchang, Henan, 461000, People's Republic of China E-mail: address
| |
Collapse
|
2
|
Sun N, Ma S, Jin L, Wang Y, Zhou C, Zhang X, Kang H, Zhou M, Yang H, Shu P. Development of AKR1B10 inhibitors from Ajuga nipponensis based on diseases and targets. Fitoterapia 2024; 172:105742. [PMID: 37952764 DOI: 10.1016/j.fitote.2023.105742] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2023] [Revised: 11/06/2023] [Accepted: 11/07/2023] [Indexed: 11/14/2023]
Abstract
Ten compounds (1-10) including one new neoclerodane diterpenoid (1) and nine known compounds were isolated from the whole plants of Ajuga nipponensis. Their structures were established by performing detailed analysis of NMR, the structure of 1 was determined using HRESIMS, 1D and 2D NMR, UV, and IR. Compounds 1 and 4-10 were isolated from Ajuga nipponensis for the first time. And it was the first time to report compounds 9 and 10 as natural products. Based on network pharmacology methods, 45 key targets were selected, which were compounds mapping to diseases. And compounds 2, 3, 7, and a (ajugacumbin B) exhibited excellent AKR1B10 inhibitory activities, with IC50 values of 53.05 ± 0.75, 87.22 ± 0.85, 61.85 ± 0.66, and 85.19±1.02 nM respectively, with Epalrestat used as the positive control (82.09 ± 1.62 nM). Additionally, the interaction between active compounds and AKR1B10 had been discussed according to the molecular docking results. Ultimately, the analysis of GO and KEGG enrichment indicated that the key signaling pathway of the active compounds may be related to prostate cancer. Our study results demonstrate the hypoglycemic and anti-tumor properties of A. nipponensis for the first time, and provide a comprehensive understanding of its application in traditional medicine. Furthermore, this article establishes a reference for further research on the optimized experimental design of novel AKR1B10 inhibitors.
Collapse
Affiliation(s)
- Na Sun
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China.
| | - Shuo Ma
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Linxuan Jin
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Yujing Wang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Caihong Zhou
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Xin Zhang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Huanhuan Kang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Miao Zhou
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Huanhuan Yang
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China
| | - Penghua Shu
- Food and Pharmacy College, Xuchang University, Xuchang, Henan 461000, People's Republic of China.
| |
Collapse
|
3
|
Syamprasad NP, Jain S, Rajdev B, Prasad N, Kallipalli R, Naidu VGM. Aldose reductase and cancer metabolism: The master regulator in the limelight. Biochem Pharmacol 2023; 211:115528. [PMID: 37011733 DOI: 10.1016/j.bcp.2023.115528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 03/25/2023] [Accepted: 03/27/2023] [Indexed: 04/03/2023]
Abstract
It is strongly established that metabolic reprogramming mediates the initiation, progression, and metastasis of a variety of cancers. However, there is no common biomarker identified to link the dysregulated metabolism and cancer progression. Recent studies strongly advise the involvement of aldose reductase (AR) in cancer metabolism. AR-mediated glucose metabolism creates a Warburg-like effect and an acidic tumour microenvironment in cancer cells. Moreover, AR overexpression is associated with the impairment of mitochondria and the accumulation of free fatty acids in cancer cells. Further, AR-mediated reduction of lipid aldehydes and chemotherapeutics are involved in the activation of factors promoting proliferation and chemo-resistance. In this review, we have delineated the possible mechanisms by which AR modulates cellular metabolism for cancer proliferation and survival. An in-depth understanding of cancer metabolism and the role of AR might lead to the use of AR inhibitors as metabolic modulating agents for the therapy of cancer.
Collapse
Affiliation(s)
- N P Syamprasad
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India
| | - Siddhi Jain
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India
| | - Bishal Rajdev
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India
| | - Neethu Prasad
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India
| | - Ravindra Kallipalli
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India
| | - V G M Naidu
- Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Sila Village, Changsari, Assam 781101, India.
| |
Collapse
|